tetano
Editor, Senior Moderator
PLoS One
. 2021 Mar 4;16(3):e0247774.
doi: 10.1371/journal.pone.0247774. eCollection 2021.
Novel outpatient management of mild to moderate COVID-19 spares hospital capacity and safeguards patient outcome: The Geneva PneumoCoV-Ambu study
Chlo? Chevallier Lugon[SUP] 1 [/SUP], Mikaela Smit[SUP] 2 3 [/SUP], Julien Salamun[SUP] 1 [/SUP], Meriem Abderrahmane[SUP] 1 [/SUP], Olivia Braillard[SUP] 1 [/SUP], Mayssam Nehme[SUP] 1 [/SUP], Fr?d?rique Jacquerioz Bausch[SUP] 1 [/SUP], Idris Guessous[SUP] 1 [/SUP], Herv? Spechbach[SUP] 1 [/SUP]
Affiliations
Abstract
Background: Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2), the novel coronavirus that causes coronavirus disease (COVID-19), is creating an unprecedented burden on health care systems across the world due to its high rate of pneumonia-related hospitalizations. This study presents recommendations for the outpatient management of moderate SARS-CoV-2 pneumonia implemented at the Geneva University Hospital, Switzerland, from April 4 to June 30, 2020 and evaluated the impact of these recommendations on patient safety, patient satisfaction, and overall hospital capacity.
Methods: Recommendations for the outpatient management of moderate pneumonia implemented in the Geneva University Hospital (PneumoCoV-Ambu) between April 4 and June 30, 2020, were evaluated prospectively. The primary endpoint was hospitalization. Secondary endpoints were: severity of COVID-19 disease based on a 7-points ordinal scale assessed at 1 and 2 months following SARS-CoV-2 infection; patient satisfaction using a satisfaction survey and the analysis of number of beds and costs potentially averted.
Results: A total of 36 patients with COVID-19-related pneumonia were followed between April 4 and May 5, 2020. Five patients (14%) were hospitalized and none died over a median of 30 days follow-up. The majority of patients (n = 31; 86%) were satisfied with the ambulatory care they received. These novel recommendations for outpatient management resulted in sparing an estimated potential 124 hospital bed-nights and CHF 6'826 per capita averted hospitalization costs over the three months period.
Conclusions: Recommendations developed for the outpatient management of COVID-19-related pneumonia were able to spare hospital capacity without increasing adverse patient outcomes. Widely implementing such recommendations is crucial in preserving hospital capacity during this pandemic.
. 2021 Mar 4;16(3):e0247774.
doi: 10.1371/journal.pone.0247774. eCollection 2021.
Novel outpatient management of mild to moderate COVID-19 spares hospital capacity and safeguards patient outcome: The Geneva PneumoCoV-Ambu study
Chlo? Chevallier Lugon[SUP] 1 [/SUP], Mikaela Smit[SUP] 2 3 [/SUP], Julien Salamun[SUP] 1 [/SUP], Meriem Abderrahmane[SUP] 1 [/SUP], Olivia Braillard[SUP] 1 [/SUP], Mayssam Nehme[SUP] 1 [/SUP], Fr?d?rique Jacquerioz Bausch[SUP] 1 [/SUP], Idris Guessous[SUP] 1 [/SUP], Herv? Spechbach[SUP] 1 [/SUP]
Affiliations
- PMID: 33662012
- DOI: 10.1371/journal.pone.0247774
Abstract
Background: Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2), the novel coronavirus that causes coronavirus disease (COVID-19), is creating an unprecedented burden on health care systems across the world due to its high rate of pneumonia-related hospitalizations. This study presents recommendations for the outpatient management of moderate SARS-CoV-2 pneumonia implemented at the Geneva University Hospital, Switzerland, from April 4 to June 30, 2020 and evaluated the impact of these recommendations on patient safety, patient satisfaction, and overall hospital capacity.
Methods: Recommendations for the outpatient management of moderate pneumonia implemented in the Geneva University Hospital (PneumoCoV-Ambu) between April 4 and June 30, 2020, were evaluated prospectively. The primary endpoint was hospitalization. Secondary endpoints were: severity of COVID-19 disease based on a 7-points ordinal scale assessed at 1 and 2 months following SARS-CoV-2 infection; patient satisfaction using a satisfaction survey and the analysis of number of beds and costs potentially averted.
Results: A total of 36 patients with COVID-19-related pneumonia were followed between April 4 and May 5, 2020. Five patients (14%) were hospitalized and none died over a median of 30 days follow-up. The majority of patients (n = 31; 86%) were satisfied with the ambulatory care they received. These novel recommendations for outpatient management resulted in sparing an estimated potential 124 hospital bed-nights and CHF 6'826 per capita averted hospitalization costs over the three months period.
Conclusions: Recommendations developed for the outpatient management of COVID-19-related pneumonia were able to spare hospital capacity without increasing adverse patient outcomes. Widely implementing such recommendations is crucial in preserving hospital capacity during this pandemic.